MCI/ PLMCIMG00012 /
- - | Chg. - | Volume | Bid- | Ask- | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
-PLN | - | - Turnover: - |
-Bid Size: - | -Ask Size: - | 1.27 bill.PLN | - | 7.71 |
GlobeNewswire
28/06
“LEQEMBI®” (Lecanemab) for the Treatment of Alzheimer’s Disease Launched in China
GlobeNewswire
25/06
NFI subsidiary Alexander Dennis receives largest single order of zero-emission buses ever, 244 next-...
GlobeNewswire
11/06
NFI subsidiary Alexander Dennis announces contract with Reading Buses for 53 buses including next-ge...
GlobeNewswire
10/06
Perspective Therapeutics Presents at the Society of Nuclear Medicine and Molecular Imaging 2024 Annu...
GlobeNewswire
10/06
FDA Accepts Eisai’s Filing of LEQEMBI® (lecanemab-irmb) Supplemental Biologics License Application f...
GlobeNewswire
30/05
L’OCCITANE en Provence and CARBIOS present a PET bottle made from enzymatic recycling, the result of...
GlobeNewswire
30/05
Green Bioactives Reports Remarkable Cognitive Benefits of its Newly Launched Memory-boosting Nutrace...
GlobeNewswire
28/05
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors Sage Therapeutics, ...
GlobeNewswire
24/05
NFI subsidiary Alexander Dennis announces contract with BC Transit for 29 double deck buses
GlobeNewswire
23/05
New Business Volume in Equipment Leasing and Finance Association’s Monthly Leasing and Finance Index...
GlobeNewswire
21/05
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors Sage Therapeutics, ...
GlobeNewswire
20/05
Perspective Therapeutics to Present at the Society of Nuclear Medicine and Molecular Imaging (SNMMI)...
GlobeNewswire
17/05
NFI subsidiary New Flyer announces contract with BC Transit for 33 battery-electric buses
GlobeNewswire
15/05
AVXL ALERT: Bragar Eagel & Squire, P.C. is Investigating Anavex Life Sciences Corp. on Behalf of Lon...
GlobeNewswire
15/05
Eisai Initiates Rolling Biologics License Application to US FDA for LEQEMBI® (lecanemab-irmb) for Su...
GlobeNewswire
14/05
IO Biotech Reports First Quarter 2024 Financial Results and Provides Business Highlights
GlobeNewswire
13/05
New Jersey awards NFI subsidiary New Flyer a contract for up to 1,300 Xcelsior® Transit Buses
GlobeNewswire
13/05
AC Immune and Takeda Sign Exclusive Option and License Agreement for Active Immunotherapy Targeting ...
GlobeNewswire
12/05
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors Sage Therapeutics, ...